BIOVIT — Bio Vitos Pharma AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual balance sheet for Bio Vitos Pharma AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	6.37	8.79	3.19	3.07	0.021
Net Total Accounts Receivable
Net Total Receivables	0.693	0.494	0.786	1.13	0.151
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	8.29	11.1	5.22	5.11	0.379
Net Property, Plant And Equipment	2.3	1.84	1.32	0.806	—
Net Intangible Assets
Total Assets	35.8	35.5	26.4	33.9	16.3
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	2.26	1.96	1.53	1.01	0.395
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	2.26	1.96	1.53	1.01	0.395
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	33.5	33.5	24.9	32.9	15.9
Total Liabilities & Shareholders' Equity	35.8	35.5	26.4	33.9	16.3
Total Common Shares Outstanding